SCHEMBL5099622

SCHEMBL5099622

CN(C)Cc1ccc(CNC(=O)c2cccc(C#N)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 10/20 0.62
LSS P48449 1/20 0.53
ALDH1A1 P00352 1/20 0.52
GAA P10253 1/20 0.51
CYP3A4 P08684 2/20 0.51
CHRM3 P20309 1/20 0.51
EPHX2 P34913 1/20 0.50
CYP2C19 P33261 1/20 0.49
ROCK1 Q13464 1/20 0.48
GPR139 Q6DWJ6 1/20 0.48
MLLT3 P42568 1/20 0.46
MLLT1 Q03111 1/20 0.46
KLKB1 P03952 1/20 0.46
KLK1 P06870 1/20 0.46
MAOA P21397 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL307593 0.89 ROCK2 (0.80) ROCK2CYP3A4CHRM3CYP2C19
SCHEMBL17142140 0.84 HDAC2 (0.64) ALDH1A1GAACHRM3EPHX2GPR139
SCHEMBL7233161 0.83 CHRM3 (0.54) ROCK2GAACHRM3EPHX2GPR139
SCHEMBL5091359 0.83 CHRM3 (0.54) ROCK2GAACHRM3EPHX2GPR139
SCHEMBL7985996 0.82 GAA (0.56) ALDH1A1GAACHRM3
SCHEMBL7989764 0.82 GAA (0.53) ROCK2ALDH1A1GAACHRM3EPHX2
SCHEMBL28146231 0.82 CHRM3 (0.55) ROCK2ALDH1A1GAACHRM3EPHX2
SCHEMBL307789 0.81 ROCK2 (0.85) ROCK2CYP3A4EPHX2CYP2C19
SCHEMBL7986109 0.81 MAOB (0.55) ALDH1A1GAACHRM3
SCHEMBL29617710 0.81 TRPV1 (0.55) ROCK2GAACHRM3EPHX2GPR139

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7425641-B2 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA KG (DE) 2008-09-16 US disclosed
US-20050065346-A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-03-24 US disclosed
EP-1206446-B1 CARBOXYLIC ACID AMIDES, THEIR PRODUCTION AND THEIR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA (DE) 2004-05-26 EP disclosed
EP-1206446-A1 CARBOXYLIC ACID AMIDES, THEIR PRODUCTION AND THEIR USE AS DRUGS Boehringer Ingelheim Pharma KG (DE) 2002-05-22 EP disclosed
WO-2001010823-A1 CARBOXYLIC ACID AMIDES, THEIR PRODUCTION AND THEIR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065346-A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions F12, F11, F2 ROCK2 3176/4885LSS 2949/4885ALDH1A1 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.